Primary pulmonary lymphoepithelioma-like carcinoma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. It is pathologically diagnosed as PLELC; 2. Immunohistochemistry or in situ hybridization of EBV coding RNAs (EBRAs) are positive; 3. Nasopharyngoscopy or CT or MRI of the Nasopharynx to rule out Nasopharyngeal carcinoma lung metastasis; 4. There are pathological tissue specimens, and there are enough tumor cells in the extracted pathological sections; 5. The PS score is evaluated according to the physical status score of the Eastern Tumor Collaborative Organization of the United States, PS 0-2;
Exclusion criteria
Exclusion criteria: 1. Incomplete clinical data and/or follow-up data; 2. Combined with other malignant tumors or mixed with other types of lung cancer; 3. Those who do not want to participate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| genomic mutation data; | — |
Countries
China
Contacts
The First Affiliated Hospital of Guangxi Medical University